The effects of HIV and aging on brain functions: Proposing a research framework and update on last 3 years' findings

Current Opinion in HIV and AIDS

Volumn 9, Issue 4, 2014, Pages 355-364

  Cysique, Lucette A ^a,b,c   Brew, Bruce J ^a,c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

Author keywords

aging; cardiovascular diseases; combined antiretroviral treatment; HIV; review

Indexed keywords

AGING; BRAIN FUNCTION; COMORBIDITY; DISEASE ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; MEDICAL RESEARCH; NERVE DEGENERATION; PRIORITY JOURNAL; REVIEW; AIDS DEMENTIA COMPLEX; BRAIN; COMPLICATION; HIV INFECTIONS; PATHOPHYSIOLOGY; PROCEDURES; TRENDS;

AGING; AIDS DEMENTIA COMPLEX; BIOMEDICAL RESEARCH; BRAIN; COMORBIDITY; HIV INFECTIONS; HUMANS;

EID: 84902255131     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0000000000000078     Document Type: Review

References (59)

1. Wendelken LA, Valcour V. Impact of HIV and aging on neuropsychological function. J Neurovirol 2012; 18:256-263.
2. Holt JL, Kraft-Terry SD, Chang L. Neuroimaging studies of the aging HIV-1-infected brain. J Neurovirol 2012; 18:291-302.
3. Cysique LA, Bain MP, Lane TA, Brew BJ. Management issues in HIVassociated neurocognitive disorders. Neurobehavioral HIV Med [serial online] 2012; 4:63-73.
4. Mateen FJ, Shinohara RT, Carone M, et al. Neurologic disorders incidence in HIV vs HIV men: multicenter AIDS cohort study. Neurology 2012; 79:1873-1880.
5. Chang L, Andres M, Sadino J, et al. Impact of apolipoprotein E epsilon4 and HIV on cognition and brain atrophy: antagonistic pleiotropy and premature brain aging. Neuroimage 2011; 58:1017-1027.
6. Brew BJ, Crowe SM, Landay A, et al. Neurodegeneration and ageing in the HAART era. J Neuroimmune Pharmacol 2009; 4:163-174.
7. Brew BJ. Neurocognitive decline and aging case presentations. Baltimore, MD, USA: 2nd International Workshop on HIV and Aging; 2011.
8. Tisch S, Brew B. Parkinsonism in HIV-infected patients on highly active antiretroviral therapy. Neurology 2009; 73:401-403.
9. Dunbar M, Murray JM, Cysique LA, et al. Simultaneous classification and feature selection via convex quadratic programming with application to HIV-associated neurocognitive disorder assessment. Eur J Oper Res 2010; 206:642-649.
10. Scott JC, Woods SP, Carey CL, et al. Neurocognitive consequences of HIV infection in older adults: an evaluation of the 'cortical' hypothesis. AIDS Behav 2011; 15:1187-1196.
11. Blanco JR, Jarrin I, Vallejo M, et al. Definition of advanced age in HIV infection: looking for an age cut-off. AIDS Res Hum Retroviruses 2012; 28:1000-1006.
12. Sacktor N, Skolasky RL, Tarwater PM, et al. Response to systemic HIV viral load suppression correlates with psychomotor speed performance. Neurology 2003; 61:567-569.
13. Morgan EE, Woods SP, Delano-Wood L, et al. Intraindividual variability in HIV infection: evidence for greater neurocognitive dispersion in older HIV seropositive adults. Neuropsychology 2011; 25:645-654.
14. Ludicello JE, Woods SP, Deutsch R, Grant I. Combined effects of aging and HIV infection on semantic verbal fluency: a view of the cortical hypothesis through the lens of clustering and switching. J Clin Exp Neuropsychol 2012; 34:476-488.
15. Patel SM, Thames AD, Arbid N, et al. The aggregate effects of multiple comorbid risk factors on cognition among HIV-infected individuals. J Clin Exp Neuropsychol 2013; 35:421-434.
16. Tan IL, Smith BR, Hammond E, et al. Older individuals with HIV infection have greater memory deficits than younger individuals. J Neurovirol 2013; 19:531-536.
17. Thames AD, Kim MS, Becker BW, et al. Medication and finance management among HIV-infected adults: the impact of age and cognition. J Clin Exp Neuropsychol 2011; 33:200-209.
18. Morgan EE, Iudicello JE, Weber E, et al. Synergistic effects of HIV infection and older age on daily functioning. J Acquir Immune Defic Syndr 2012; 61:341-348.
19. Pfefferbaum A, Rogosa DA, Rosenbloom MJ, et al. Accelerated aging of selective brain structures in human immunodeficiency virus infection: a controlled, longitudinal magnetic resonance imaging study. Neurobiol Aging 2014; 35:1755-1768.
20. Jahanshad N, Valcour VG, Nir TM, et al. Disrupted brain networks in the aging HIV population. Brain Connect 2012; 2:335-344.
21. Harezlak J, Buchthal S, Taylor M, et al. Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment. AIDS 2011; 25:625-633.
22. Cysique LA, Lane T, Moffat K, et al. HIV, vascular and aging injuries in the brain of clinically stable HIV-infected adults: a 1H MRS study. Plos One 2013; 8:e61738.
23. Chang L, Holt JL, Yakupov R, et al. Lower cognitive reserve in the aging human immunodeficiency virus-infected brain. Neurobiol Aging 2013; 34:1240-1253.
24. Cysique LA, Maruff P, Bain MP, et al. HIV and age do not substantially interact in HIV-associated neurocognitive impairment. J Neuropsychiatry Clin Neurosci 2011; 23:83-89.
25. Valcour V, Paul R, Neuhaus J, Shikuma C. The effects of age and HIV on neuropsychological performance. J Int Neuropsychol Soc 2011; 17:190-195.
26. Ciccarelli N, Fabbiani M, Baldonero E, et al. Effect of aging and human immunodeficiency virus infection on cognitive abilities. J Am Geriatr Soc 2012; 60:2048-2055.
27. Towgood KJ, Pitkanen M, Kulasegaram R, et al. Mapping the brain in younger and older asymptomatic HIV-1 men: frontal volume changes in the absence of other cortical or diffusion tensor abnormalities. Cortex 2012; 48:230-241.
28. Ances BM, Ortega M, Vaida F, et al. Independent effects of HIV, aging, and HAART on brain volumetric measures. J Acquir Immune Defic Syndr 2012; 59:469-477.
29. Becker JT, Maruca V, Kingsley LA, et al. Factors affecting brain structure in men with HIV disease in the post-HAART era. Neuroradiology 2012; 54:113-121.
30. Nir TM, Jahanshad N, Busovaca E, et al. Mapping white matter integrity in elderly people with HIV. Hum Brain Mapp 2014; 35:975-992.
31. Thomas JB, Brier MR, Snyder AZ, et al. Pathways to neurodegeneration: effects of HIV and aging on resting-state functional connectivity. Neurology 2013; 80:1186-1193.
32. Grima P, Fabbiani M, Ciccarelli N, et al. Increased ophthalmic artery resistance index is associated with cognitive impairment in HIV-infected patients. J Infect 2012; 65:439-446.
33. McCutchan JA, Marquie-Beck JA, Fitzsimons CA, et al. Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder. Neurology 2012; 78:485-492.
34. Fabbiani M, Ciccarelli N, Tana M, et al. Cardiovascular risk factors and carotid intima-media thickness are associated with lower cognitive performance in HIV-infected patients. HIV Med 2013; 14:136-144.
35. Nakamoto BK, Jahanshad N, McMurtray A, et al. Cerebrovascular risk factors and brain microstructural abnormalities on diffusion tensor images in HIVinfected individuals. J Neurovirol 2012; 18:303-312.
36. Soontornniyomkij V, Moore DJ, Gouaux B, et al. Cerebral beta-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE epsilon4 carriers. Aids 2012; 26:2327-2335.
37. Steinbrink F, Evers S, Buerke B, et al. Cognitive impairment in HIV infection is associated with MRI and CSF pattern of neurodegeneration. Eur J Neurol 2013; 20:420-428.
38. Salthouse TA. Selective review of cognitive aging. J Int Neuropsychol Soc 2010; 16:754-760.
39. Cysique LA, Franklin D Jr, Abramson I, et al. Normative data and validation of a regression based summary score for assessing meaningful neuropsychological change. J Clin Exp Neuropsychol 2011; 7:1-18.
40. Bland JM, Altman DG. Statistic notes: regression towards the mean. BMJ 1994; 308:1499.
41. Foley JM, Ettenhofer ML, Kim MS, et al. Cognitive reserve as a protective factor in older HIV-positive patients at risk for cognitive decline. Appl Neuropsychol Adult 2012; 19:16-25.
42. Cysique LA, Bain MP, Brew BJ, Murray JM. The burden of HIV-associated neurocognitive impairment in Australia and its estimates for the future. Sex Health 2011; 8:541-550.
43. D'Agostino RB Sr, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008; 117:743-753.
44. Alcaide ML, Parmigiani A, Pallikkuth S, et al. Immune activation in HIV-infected aging women on antiretrovirals-implications for age-associated comorbidities: a cross-sectional pilot study. PLoS One 2013; 8:e63804.
45. Crystal HA, Weedon J, Holman S, et al. Associations of cardiovascular variables and HAART with cognition in middle-aged HIV-infected and uninfected women. J Neurovirol 2011; 17:469-476.
46. Gustafson DR, Mielke MM, Tien PC, et al. Anthropometric measures and cognition in middle-aged HIV-infected and uninfected women. The Women's Interagency HIV Study. J Neurovirol 2013; 19:574-585.
47. Rubin LH, Sundermann EE, Cook JA, et al. Investigation of menopausal stage and symptoms on cognition in human immunodeficiency virus-infected women. Menopause 2014. [Epub ahead of print]
48. Valcour V, Maki P, Bacchetti P, et al. Insulin resistance and cognition among HIV-infected and HIV-uninfected adult women: the Women's Interagency HIV Study. AIDS Res Hum Retroviruses 2012; 28:447-453.
49. Rodriguez-Penney AT, Iudicello JE, Riggs PK, et al. Co-morbidities in persons infected with HIV: increased burden with older age and negative effects on health-related quality of life. AIDS Patient Care STDS 2013; 27:5-16.
50. Vance DE. The cognitive consequences of stigma, social withdrawal, and depression in adults aging with HIV. J Psychosoc Nurs Ment Health Serv 2013; 51:18-20.
51. Fumaz CR, Munoz-Moreno JA, Ferrer MJ, et al. Emotional impact of premature aging symptoms in long-term treated HIV-infected subjects. J Acquir Immune Defic Syndr 2012; 59:e5-8.
52. Ludicello JE, Morgan EE, Gongvatana A, et al. Detrimental impact of remote methamphetamine dependence on neurocognitive and everyday functioning in older but not younger HIV adults: evidence for a legacy effect? J Neurovirol 2014; 20:85-98.
53. Pfefferbaum A, Rosenbloom MJ, Sassoon SA, et al. Regional brain structural dysmorphology in human immunodeficiency virus infection: effects of acquired immune deficiency syndrome, alcoholism, and age. Biol Psychiatry 2012; 72:361-370.
54. Watkins CC, Treisman GJ. Neuropsychiatric complications of aging with HIV. J Neurovirol 2012; 18:277-290.
55. Ghidei L, Simone MJ, Salow MJ, et al. Aging, antiretrovirals, and adherence: a meta analysis of adherence among older HIV-infected individuals. Drugs Aging 2013; 30:809-819.
56. Cysique LA, Heaton RK, Kamminga J, et al. HIV-associated neurocognitive disorder in Australia: a case of a high-functioning and optimally treated cohort and implications for international neuroHIV research. J Neurovirol; In press.
57. McCombe JA, Vivithanaporn P, Gill MJ, Power C. Predictors of symptomatic HIV-associated neurocognitive disorders in universal healthcare. HIV Med 2013; 14:99-107.
58. Pathai S, Bajillan H, Landay AL, High KP. Is HIV a model of accelerated or accentuated aging? J Gerontol A Biol Sci Med Sci 2013. doi: 10. 1093/ gerona/glt168.
59. Hopcroft L, Bester L, Clement D, et al. 'My body's a 50 year-old but my brain is definitely an 85 year-old': exploring the experiences of men ageing with HIVassociated neurocognitive challenges. J Int AIDS Soc 2013; 16:18506.